BoE's Ben Broadbent Tells CNBC: Bernanke's QE Remarks Were Not Surprising
Investment Strategy
featured
Stephen Koseff, CEO of Investec, talks about full-year earnings and the company's strategy of diversifying away from capital intensive business.
» Read More
More
-
Groundhog Day, deja vu. Stop me if you've heard any of this before: volume light, no real sellers...half-hearted-attempt to push market down at the open has no legs, shorts cover immediately...Trichet says that speculation that Greece will exit from Euro zone was "absurd." All the above happened today, again.
-
Stocks ended higher Monday, led by health care, as passage of the health-care bill lifted uncertainty surrounding the legislation that was hanging over the market. Citigroup jumped after an analyst upgrade.
-
One of the most fascinating business and investing stories we’ve all been following is whether Google would follow through on its threat to shut down some or all of its operations in China.
-
Are dividend stocks back and should you be investing in them? Dan Genter, president, CEO and CIO of RNC Genter Capital Management, and Paul Schatz, president at Heritage Capital, shared their insights.
-
Yes, futures were weak at the open on two events: 1) many traders were short the market on expectations that healthcare reform passage would rattle stocks, and 2) more uncertainty over the EU's commitment to Greece. But then two things happened...
-
Stocks bounced back from a lower open Monday as all the uncertainty surrounding the health bill lifted after the House approved it. Merck and Pfizer remained at the front of the Dow pack. Citigroup jumped after an analyst upgrade.
-
The S&P Health Care Index has been seeing a boost from the health care bill. Will the stocks continue to get a lift from the new legislation—and how should you play the sector? Ipsita Smolinski, president and health care analyst at Capitol Street, and Carl McDonald, health care analyst and managed care analyst at Oppenheimer, discussed their views.
-
Many companies are announcing dividend hikes this month—a reversal from last year and the year before. So where should investors place their money? Jeff Krumpelman, dividend growth portfolio manager at Hilliard Lyons Capital Management, and Stanley Nabi, chief strategist at Silvercrest Asset Management, offered their best dividend plays.
-
The House gave final approval to a sweeping health care overhaul on Sunday, expanding insurance coverage to nearly all Americans. How will markets trade from here? Jamie Cox, managing partner at Harris Financial Group and Uri Landesman, head of global growth at ING Investment Management shared their market insights.
-
A truly special edition of the Closing Bell w/Maria Bartiromo this afternoon. We are LIVE from Yankee Stadium from 3-5PM ET. Pepsico is holding its two day analysts meeting there.
-
While the historic health care vote dominated headlines, we are seeing weakness this morning out of Asia, where India's Sensex Index dropped 1 percent in response to Friday's quarter point rate hike. There's also weakness in Europe, as Greece is down another 3.2 percent on uncertainty about what, if any, support Greece may get with its debt crisis...
-
Stocks opened lower as the dollar gained amid worries about Greece's debt crisis. Health-care stocks were one of the few sectors higher today following the weekend passage of U.S. health-care reform.
-
As Google prepares to close and exit its China search engine operation, how should investors be playing the company’s stock? Clayton Moran, senior vice president and Internet analyst at The Benchmark Company, shared his insights.
-
The Shanghai Stock Index could push higher toward 3,400 points or above if it can manage to break out of its current trading range, Daryl Guppy, CEO of Guppytraders.com, told CNBC Monday.
-
Sterling is undervalued against the euro. Just about every trading desk that I talk to seems to think so. However, very few of them tell me that they will be willing to back the pound until the general election is over.
-
Global stocks were lower on Monday as the passage of President Obama's health care reform by the House of Representatives weighed on pharmaceutical stocks, as well as investors worrying over Greece's future as European Union leaders meet.
-
Equity markets have switched from fear to outright complacency in the space of one year and are ignoring the warning signs, according to SquawkBox Europe's guest host, Phillippe Gijsels, head of research at BNP Paribas Fortis Global Markets.
-
U.S. stock index futures fell Monday as Wall Street focused on the health care reform following the passage of the historic health care bill by the House of Representatives late Sunday night.
-
The Democrats' health care reform package could bring a dose of bad medicine for stocks if it passes this weekend, at least in the immediate term.
-
Stocks turned lower Friday as taxes in the health bill roiled Wall Street. Scott Redler, chief strategic officer at T3live.com, and Mike Rubino, president of Rubino Financial, shared their insights.